Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
30.69
+0.97 (3.26%)
At close: Oct 23, 2026, 4:00 PM EDT
30.63
-0.06 (-0.20%)
After-hours: Oct 23, 2026, 7:42 PM EDT
Alamar Biosciences Revenue
Alamar Biosciences had revenue of $29.43M in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to $100.42M. In the year 2025, Alamar Biosciences had annual revenue of $74.21M with 195.17% growth. That makes Alamar Biosciences the 22,596th largest company in the world by revenue and 3,286th in the United States.
Revenue (ttm)
$100.42M
Revenue Growth
+195.17%
P/S Ratio
21.21
Revenue / Employee
$351,119
Employees
286
Market Cap
2.13B
Revenue by Geography
- United States 45.42M 61.2%
- Europe, Middle East and Africa (Excluding Germany) 14.12M 19.0%
- Germany 8.31M 11.2%
- Asia-Pacific 5.82M 7.8%
- Rest of The World 539.00K 0.7%
Fiscal year ended Dec 31, 2025 See the full Alamar Biosciences breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 74.21M | 49.07M | 195.17% |
| Dec 31, 2024 | 25.14M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
ALMR News
- 11 days ago - Cathie Wood’s ARK Investment buys 101K shares of Alamar Biosciences today - TheFly
- 15 days ago - Alamar Biosciences to Report Third Quarter 2026 Financial Results on November 3, 2026 - GlobeNewsWire
- 18 days ago - Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team - GlobeNewsWire
- 4 weeks ago - Lancet study using Alamar’s technology reveals divergent responses to Alzheimers - TheFly
- 4 weeks ago - Lancet Neurology Study Using Alamar Biosciences' Technology Reveals Divergent Biological Responses to Alzheimer's Treatment - GlobeNewsWire
- 5 weeks ago - Alamar Biosciences rises 15.1% - TheFly
- 5 weeks ago - Alamar Biosciences rises 9.4% - TheFly
- 5 weeks ago - Alamar Biosciences Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts